(Updated - September 7, 2022 3:37 AM EDT)

UBS analyst John Sourbeer initiates coverage on Medpace (NASDAQ: MEDP) with ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE